68036-47-5Relevant articles and documents
-
Mazzocchi et al.
, p. 50,53 (1979)
-
Lactone enol cation-radicals: Gas-phase generation, structure, energetics, and reactivity of the ionized enol of butane-4-lactone
Turecek, Frantisek,Vivekananda, Shetty,Sadilek, Martin,Polasek, Miroslav
, p. 829 - 839 (2002)
The cation-radical of 2-hydroxyoxol-2-ene (1+?) represents the first lactone enol ion whose structure and gas-phase ion chemistry have been studied by experiment and theory. Ion 1+? was generated by the McLafferty rearrangement in ionized 2-acetylbutane-4-lactone and characterized by accurate mass measurements, isotope labeling, metastable ion and collisionally activated dissociation (CAD) spectra. Metastable 1+? undergoes competitive losses of H-4 and CO that show interesting deuterium and 13C isotope effects. The elimination of CO from metastable 1+? shows a bimodal distribution of kinetic energy release and produces ?CH2CH2CH=OH+ (14+?) and CH3CH=CHOH+? (15+?) in ratios which are subject to deuterium isotope effects. Ab initio calculations at the G2(MP2) level of theory show that 1+? is 105 kJ mol-1 more stable than its oxo form, [butane-4-lactonel]+?(2+?). The elimination of CO from 1+? involves multiple isomerizations by hydrogen migrations and proceeds through ion-molecule complexes of CO with 14+? and 15+?. In addition, CO is calculated to catalyze an exothermic isomerization 14+? → 15+? in the ion-molecule complexes. Multiple consecutive hydrogen migrations in metastable 1+?, as modeled by RRKM calculations on the G2(MP2) potential energy surface, explain the unusual deuterium kinetic isotope effects on the CO elimination. Copyright
4-HYDROXYBUTYRIC ACID DEUTERATED ANALOGS
-
Page/Page column 44, (2012/09/10)
This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing. This invention also provides pharmaceutical compositions comprising a compound of this invention and the use of such compositions in methods of treating narcolepsy, fibromyalgia, other disorders or conditions that are beneficially treated by improving nocturnal sleep or by administering sodium oxybate.